Leptospirosis Registry - LeptoScope
University of Cologne
200 participants
Mar 4, 2020
OBSERVATIONAL
Conditions
Summary
Leptospirosis is a worldwide zoonotic diseases caused by pathogenic Leptospira spp. Human are accidental hosts, who acquired infections after exposition to animal urine, contaminated water or soil, infected tissue. Incidence of invasive leptospirosis disease causing acute kidney injury, acute respiratory distress syndrome (ARDS), myocarditis, hepatic dysfunction, hemorrhage and multi-organ failure, is globally increasing and there have been frequent outbreak situation throughout the world. Due to increasing outbreak situations and globally chances in species distributions, a worldwide surveillance in epidemiology and species distribution is urgently needed. The objective of the Leptospirosis Registry - LeptoScope is to overcome the lack knowledge on epidemiology, clinical course, prognostic factors and molecular characteristics for invasive leptospirosis disease.
Eligibility
Inclusion Criteria3
- Cultural, serological, molecular or histological evidence of invasive leptospirosis diseases
- Clinical signs of disseminated leptospirosis disease without cultural, serological, molecular or histological evidence
- Case controls: Matching procedures for controls: Particularly, case controls will be included at the same hospitals that conduced cases based on matching of demographics, underlying diseases and duration of hospitalization (i.e. one control per case, both in the same hospital).
Exclusion Criteria2
- Colonization or other non-invasive infection
- Cultural, serological, molecular or histological evidence without dissemination
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Retrospective data collection of demographics from patients with leptospirosis and matching control group patients.
Retrospective data collection of underlying diseases from patients with leptospirosis and matching control group patients.
Retrospective data collection of duration of hospitalization from patients with leptospirosis and matching control group patients.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04288674